SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-043425
Filing Date
2022-04-07
Accepted
2022-04-07 07:15:33
Documents
14
Period of Report
2022-04-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2212134d1_8k.htm   iXBRL 8-K 25491
2 EXHIBIT 99.1 tm2212134d1_ex99-1.htm EX-99.1 14129
6 GRAPHIC tm2212134d1_ex99-1img001.jpg GRAPHIC 13783
  Complete submission text file 0001104659-22-043425.txt   238303

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aptx-20220407.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20220407_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20220407_pre.xml EX-101.PRE 22593
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2212134d1_8k_htm.xml XML 3706
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 22812286
SIC: 2834 Pharmaceutical Preparations